Pricing

Aileron Therapeutics Inc (ALRN)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
SERVICES-SOCIAL SERVICES
CEO:
Manuel C. Alves Aivado
Employees:
9
738 MAIN STREET, UNIT 398, WALTHAM, MA, 02451
617-995-0900

Are you looking for this stock instead?

Stock Split History
DateRatio
2022-11-11 1:20
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. Company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available